Vertex Pharmaceuticals VRTX
NASDAQ VRTX
$522.38 +6.04 (+1.17%)
At close: Sep 24, 2026 · 4:00 PM EDT

Vertex Pharmaceuticals (VRTX) Long-Term Debt Issuances (2009 - 2021)

Vertex Pharmaceuticals (VRTX) posted Long-Term Debt Issuances of $10.0 million for Q4 2021, up 900.0% on a QoQ basis from $1.0 million in Q3 2021, and up 114.68% year-over-year from $4.7 million in Q4 2020.

Analysis

Vertex Pharmaceuticals (VRTX) Long-Term Debt Issuances (2009 - 2021) Analysis & Trends

Vertex Pharmaceuticals has reported Long-Term Debt Issuances for 11 years, with the latest figure at $10.0 million in Q4 2021.

  • On a quarterly basis, Long-Term Debt Issuances rose 114.68% year-over-year to $10.0 million in Q4 2021; TTM through Sep 2022 was $10.0 million, a 42.06% decrease from a year earlier, with the FY2021 full-year figure at $22.6 million, up 69.92% from the prior year.
  • Long-Term Debt Issuances was $10.0 million for Q4 2021 at Vertex Pharmaceuticals, up from $1.0 million in the prior quarter.
  • The five-year high for Long-Term Debt Issuances was $30.0 million in Q4 2017, with the low at $1.0 million in Q3 2021.
  • Average Long-Term Debt Issuances over 5 years is $7.2 million, with a median of $5.3 million recorded in 2017.
  • The sharpest annual moves came in 2017 and 2018: Long-Term Debt Issuances soared 131.53% in 2017, then plunged 73.78% in 2018.
  • Over 5 years, Long-Term Debt Issuances stood at $30.0 million in 2017, then slumped by 73.78% to $7.9 million in 2018, then rose by 14.52% to $9.0 million in 2019, then tumbled by 48.23% to $4.7 million in 2020, then surged by 114.68% to $10.0 million in 2021.
  • The last three Long-Term Debt Issuances figures came in at $10.0 million (Q4 2021), $1.0 million (Q3 2021), and $8.0 million (Q2 2021), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) LT Debt Issuance (Qtr)
1 Johnson & Johnson 649.01 Bn 628.25 Bn 17.26 Bn -
2 AbbVie 468.55 Bn 462.03 Bn 12.70 Bn -
3 Merck 365.49 Bn 358.40 Bn 12.21 Bn -
4 Novartis Ag 272.39 Bn 265.10 Bn 11.24 Bn 1.98 Bn
5 Astrazeneca 253.18 Bn 247.96 Bn 12.86 Bn -
6 Amgen 219.53 Bn 205.54 Bn 7.24 Bn -
7 Gilead Sciences 187.85 Bn 184.59 Bn 6.22 Bn 1.32 Bn
8 Pfizer 160.56 Bn 149.16 Bn 10.94 Bn -
9 Vertex Pharmaceuticals 130.81 Bn 122.96 Bn 2.84 Bn -
10 Bristol Myers Squibb 124.95 Bn 113.89 Bn 9.25 Bn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2021 10.00 Mn
Sep 30, 2021 1.00 Mn
Jun 30, 2021 8.00 Mn
Mar 31, 2021 3.60 Mn
Dec 31, 2020 4.66 Mn
Sep 30, 2020 2.81 Mn
Mar 31, 2020 5.83 Mn
Dec 31, 2019 9.00 Mn
Jun 30, 2019 1.00 Mn
Dec 31, 2018 7.86 Mn
Sep 30, 2018 3.42 Mn
Mar 31, 2018 9.57 Mn
Dec 31, 2017 29.97 Mn
Sep 30, 2017 4.70 Mn
Dec 31, 2016 72.97 Mn
Sep 30, 2016 2.03 Mn
Dec 31, 2015 10.28 Mn
Mar 31, 2015 13.39 Mn
Dec 31, 2014 294.24 Mn
Dec 31, 2011 105.00 Mn
API Access

Vertex Pharmaceuticals Long-Term Debt Issuances API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=long-term-debt-issuances&ticker=VRTX&period=max&api_key=YOUR_API_KEY